tiprankstipranks
Advertisement
Advertisement

Curaleaf Sets May 5 Date to Release Q1 2026 Results and Host Investor Call

Story Highlights
  • Curaleaf, a leading international cannabis products company, operates across medical and adult-use markets through multiple brands.
  • The company will release its first-quarter 2026 financial and operational results on May 5, followed by an investor conference call and webcast.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Curaleaf Sets May 5 Date to Release Q1 2026 Results and Host Investor Call

Claim 55% Off TipRanks

Curaleaf Holdings ( (TSE:CURA) ) just unveiled an announcement.

Curaleaf Holdings, Inc., a major international cannabis consumer products company with operations across medical and adult-use markets and a vertically integrated presence in Europe, Canada, and Australasia, continues to expand its portfolio through brands such as Curaleaf, Select, Grassroots, Find, and Anthem. The company announced it will release its financial and operational results for the first quarter of 2026 after markets close on May 5, 2026, followed by a management-hosted conference call and webcast, signaling upcoming insights into its performance and strategic trajectory for investors and industry stakeholders.

The scheduled call, set for 5:00 p.m. ET on May 5, will feature prepared remarks and a question-and-answer session focused on operational and financial highlights, and a replay will be available for those unable to attend live. This disclosure timeline positions Curaleaf to update the market on early 2026 trends in its international cannabis operations, potentially providing clarity on growth initiatives, competitive positioning, and broader sector dynamics following the quarter’s close.

The most recent analyst rating on (TSE:CURA) stock is a Hold with a C$2.50 price target. To see the full list of analyst forecasts on Curaleaf Holdings stock, see the TSE:CURA Stock Forecast page.

Spark’s Take on CURA Stock

According to Spark, TipRanks’ AI Analyst, CURA is a Neutral.

The score is held back primarily by persistent net losses, margin compression, and weak technical trends (negative MACD and trading below key moving averages). Offsetting factors include improving cash generation and management’s operational progress and de-risking actions discussed on the earnings call (notably cash flow strength and refinancing), but near-term revenue softness and continued pricing pressure limit upside.

To see Spark’s full report on CURA stock, click here.

More about Curaleaf Holdings

Curaleaf Holdings, Inc. is a leading international cannabis company that provides consumer products across medical and adult-use markets. Through brands such as Curaleaf, Select, Grassroots, Find, and Anthem, it offers a broad range of cannabis products supported by a vertically integrated supply chain and distribution network spanning Europe, Canada, and Australasia, and is listed on the Toronto Stock Exchange and OTCQX.

Average Trading Volume: 574,406

Technical Sentiment Signal: Sell

Current Market Cap: C$2.05B

Learn more about CURA stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1